ArticleCurrent oncology (Toronto, Ont.)2023

Decitabine/Cedazuridine in the Management of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia in Canada.

John Paul Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.